Literature DB >> 30734487

C-reactive protein to albumin ratio is a key indicator in a predictive model for anastomosis leakage after esophagectomy: Application of classification and regression tree analysis.

Chen-Ye Shao1, Kai-Chao Liu2, Chu-Ling Li1, Zhuang-Zhuang Cong2, Li-Wen Hu2, Jing Luo2, Yi-Fei Diao3, Yang Xu1, Sai-Guang Ji4, Yong Qiang3, Yi Shen1,2.   

Abstract

BACKGROUND: Anastomotic leakage (AL), a serious complication after esophagectomy, might impair patient quality of life, prolong hospital stay, and even lead to surgery-related death. The aim of this study was to show a novel decision model based on classification and regression tree (CART) analysis for the prediction of postoperative AL among patients who have undergone esophagectomy.
METHODS: A total of 450 patients (training set: 356; test set: 94) with perioperative information were included. A decision tree model was established to identify the predictors of AL in the training set, which was validated in the test set. A receiver operating characteristic curve was also created to illustrate the diagnostic ability of the decision model.
RESULTS: A total of 12.2% (55/450) of the 450 patients suffered AL, which was diagnosed at median postoperative day 7 (range: 6-16). The decision tree model, containing surgical duration, postoperative lymphocyte count, and postoperative C-reactive protein to albumin ratio, was established by CART analysis. Among the three variables, the postoperative C-reactive protein to albumin ratio was identified as the most important indicator in the CART model with normalized importance of 100%. According to the results validated in the test set, the sensitivity, specificity, positive and negative predictive value, and diagnostic accuracy of the prediction model were 80%, 98.8%, 88.9%, 97.6%, and 96.8%, respectively. Moreover, the area under the receiver operating characteristic curve was 0.95.
CONCLUSION: The decision model based on CART analysis presented good performance for predicting AL, and might allow the early identification of patients at high risk.
© 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Anastomotic leak; C-reactive protein; decision tree; esophagectomy; logistic model

Mesh:

Substances:

Year:  2019        PMID: 30734487      PMCID: PMC6449232          DOI: 10.1111/1759-7714.12990

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


Introduction

The morbidity and mortality resulting from anastomotic leakage (AL) after esophagectomy have steadily decreased during the last several decades with improvements in surgical techniques and management during the perioperative period1 In spite of these advances, AL remains a significant cause of surgery‐related death and an impairment to quality of life2 AL prolongs hospital stay, increases expenses, and has been proven to be associated with postoperative tumor recurrence3 Without timely or correct treatment, AL can lead to severe chest or mediastinal infections, which can be life‐threatening4 Therefore, it is particularly important to construct methods that could help to identify high‐risk postoperative patients in order to administer timely treatment. The process of AL development induces a strong systematic inflammatory response. Previous studies have shown that some circulating acute phase proteins (such as C‐reactive protein [CRP] and albumin) are associated with surgery‐related systematic inflammatory response5 Postoperative CRP has been assessed as a good indicator for the early detection of AL after colorectal surgery and esophagectomy and in rectal cancer and esophageal cancer in both neoadjuvant and non‐neoadjuvant patients6, 7, 8 Albumin is a sensitive response indicator to surgical stress; postoperative albumin has been evaluated as a potential predictor of clinical complications9 A novel indicator, the CRP to albumin ratio (CAR), is used to identify patients who have a high probability of postoperative complications; the diagnostic accuracy of the ratio is superior to CRP alone for the prediction of postoperative complications after colorectal surgery10 However, few studies have reported an association between CAR and AL after esophagectomy. In this study, we hypothesized that postoperative CAR could be a potential predictor for AL after esophagectomy. In addition, the mainstream methods for predicting AL after esophagectomy are based on traditional statistical techniques (e.g. logistic regression, Cox proportional hazards regression) and some serological and biochemical indicators4, 11, 12, 13 However, shortcomings in traditional regression analysis exist. Particularly, in this study, CAR as a composite indicator has a multicollinearity relationship with CRP and albumin, which may lead to the wrong identification of relevant predictors in regression analysis14 Classification and regression tree (CART), as a data mining technique, is ideally suitable for the generation of clinical rules, which often enables the detection of complex interactions between predictors (including predictors with multicollinearity), which may be difficult or impossible to uncover using traditional statistical techniques15 CART has been shown to perform as well or better than other traditional statistical techniques, such as logistic regression analysis, and is increasingly being applied to diagnose disease and predict outcomes or complications in patients, including diabetes, trauma, and cancer.16, 17, 18, 19 To the best of our knowledge, CART analysis has not previously been used to assess the predictors of AL in patients after esophagectomy. In the present study, we used CART analysis to construct a decision model for predicting the presence of AL in patients after esophagectomy using perioperative data (including CAR) and then evaluated the predictive performance of the decision model.

Methods

General information

The data of 461 patients who underwent esophagectomy and reconstruction of the esophageal tract in Jinling Hospital of Nanjing Medical University from January 2017 to April 2018 were retrospectively evaluated and enrolled. Patients were diagnosed by pathological examination of tumor tissue obtained during surgery. Of the 461 patients, we excluded four cases without sufficient clinicopathological data, five who suffered from distant metastasis, and two who died of early cancer recurrence. Of the remaining 450 cases, 353 men and 97 women were included (mean age 64.26 ± 8.4 years). The perioperative data of the 450 patients were collected and summarized and included: gender, age, body mass index, history of prior chemotherapy and/or radiotherapy, diabetes, smoking history, drinking history, chest operation history, and location of tumor recorded from the postoperative histology findings. The biochemical parameters included preoperative: leukocyte, lymphocyte, neutrophil, erythrocyte, hemoglobin, thrombocyte, CRP, and albumin counts. The surgery‐related data included were the duration of surgical produce (from skin incision to closure), American Society of Anesthesiologists (ASA) score, methods of anastomosis, and the type of surgery. The following surgical parameters were considered: tumor size, tumor histology, pathologic tumor stage, and tumor differentiation. In all cases, white blood cells (WBCs), lymphocytes, neutrophils, red blood cells (RBCs), hemoglobin (Hb), thrombocyte, CRP, and albumin were measured on the third postoperative day (POD 3). None of the patients in our study were administered intravenous albumin supplementation. The postoperative CAR was calculated based on the results of laboratory tests. The calculation formula is as follows: CAR = (CRP on POD3)/(albumin on POD 3).

Definition of anastomotic leakage

AL was defined as follows: (i) the disruption of the anastomosis that leads to the outflow of the intraluminal content, which is sufficient to cause clinical symptoms20 and/or (ii) leaks confirmed by chest computed tomography, endoscopy, or surgical exploration.

Decision tree modeling and validation

The 450 cases were split into two sets (training set with 356 patients; test set with 94 patients) according to the principle of simple random sampling. The training set was used to construct the decision tree model, which was then verified by the test set. All patients agreed to participate and signed informed consent. The Institutional Ethics Committee approved the study based on the principles of the Declaration of Helsinki. Univariable analysis was performed to screen the candidate variables. CART was then performed on the training set to construct a decision tree model using these candidate variables. Beginning with a root node that contained all patients in the training set, all candidate variables were checked by recursive iterative algorithm to find the best variable to split the root node into two branches based on the Gini impurity index21 The tree branches were then divided into different child nodes that included a subgroup of patients. The process of node splitting was repeated for each predictor in the model and continued recursively until the cases were divided into two homogeneous groups: with and without AL.22 Pre pruning was carried out to avoid overfitting the CART model. The maximum tree depth was set to three layers; the minimum cases of parent and child node were both set to five. The optimal tree model was selected according to its predictive accuracy and clinical relevance. The performance of the prediction model was validated by the test set. In order to evaluate the accuracy of the prediction model, we calculated the overall sensitivity, specificity, false positive and negative rates, positive and negative predictive values, and diagnostic accuracy of the model and established receiver operating characteristic (ROC) curves.

Statistical analysis

We used the χ2 or Fisher's exact test, as appropriate, for categorical variables. A Shapiro–Wilk test was used to assess whether the continuous data was normally distributed. On the basis of the results of the Shapiro–Wilk test, continuous variables were compared using Student's t or Mann–Whitney non‐parametric tests, as appropriate. Data were analyzed using SPSS version 21.0 (IBM Corp., Armonk, NY, USA). P values < 0.05 were defined as statistically significant.

Results

Patient characteristics

The prevalence of AL among 450 patients was 12.2% (55/450). Patients with AL in this study were diagnosed at median postoperative day 7 (range: 6–16). Characteristics of the training and validation datasets are presented in Table 1. There were no statistical differences between the two groups in any of the 35 variables studied (P > 0.05), indicating that clinical characteristics in the two data sets were well distributed. Considering that leakages at cervical anastomosis and intrathoracic anastomosis may cause different degrees of infection, we performed independent sample T analysis to identify whether there was a statistical difference between the two methods. A total of 55 patients suffered from AL; there was no statistical difference between the CARs of the two anastomotic methods: (cervical anastomosis n = 45, CAR value: 5.67 ± 2.54; intrathoracic anastomosis n = 10, CAR value: 5.64 ± 2.59; P = 0.97). The non‐AL group consisted of 395 patients; the results of independent sample T analysis were: cervical anastomosis (n = 291) CAR value: 2.01 ± 1.84; intrathoracic anastomosis (n = 104) CAR value: 1.67 ± 1.34 (P = 0.09).
Table 1

Characteristics of patients used in the data set

No.VariableTraining (n = 356) Test (n = 94) P
1Gender
Male281720.90
Female7522
2Age (years)64.34 ± 8.4164.12 ± 8.390.82
3BMI (kg/m2)23.01 ± 3.2223.19 ± 3.160.57
4History of prior chemotherapy and/or radiotherapy
Yes292830.16
No6411
5Diabetes
Yes331880.83
No256
6Smoking history
Yes177470.96
No17947
7Drinking history
Yes199590.23
No15735
8Chest operation history
Yes350930.80
No61
9Location of tumor
Upper3540.16
Middle21556
Lower10634
10Preoperative WBC (109/L)5.81 ± 1.975.68 ± 1.700.53
11Preoperative lymphocyte (109/L)1.66 ± 0.561.65 ± 0.590.85
12Preoperative neutrophil (109/L)3.61 ± 1.803.51 ± 1.490.62
13Preoperative RBC (1012/L)4.31 ± 0.564.42 ± 0.460.10
14Preoperative Hb (g/L)131.6 ± 19.9132.0 ± 15.50.25
15Preoperative thrombocyte (109/L)188.6 ± 60.8204.3 ± 68.90.26
16Preoperative CRP (mg/L)6.3 ± 22.64.14 ± 6.00.35
17Preoperative albumin (g/L)41.17 ± 4.6641.90 ± 4.190.16
18ASA score
1288770.97
25714
3113
19Method of anastomosis
Cervical anastomosis267690.75
Intrathoracic anastomosis8925
20Type of surgery
Open operation180490.08
VATS13527
RATS4118
21Tumor size (cm)
< 3129310.77
3–515645
> 57118
22Tumor histology
SCC326890.62
AC51
ASC21
Other233
23Pathologic tumor stage
I140360.96
II7521
III13035
IV112
24Tumor differentiation
High96220.72
Medium21461
Low4611
25Surgical duration (minutes)246.4 ± 65.8244.9 ± 68.50.54
26Postoperative WBC (109/L)11.12 ± 3.3611.30 ± 3.370.64
27Postoperative lymphocyte count (109/L)0.74 ± 0.340.78 ± 0.360.15
28Postoperative neutrophil count (109/L)9.72 ± 3.169.83 ± 3.200.76
29Postoperative RBC (1012/L)3.84 ± 0.583.88 ± 0.470.13
30Postoperative Hb (g/L)116.9 ± 19.3118.9 ± 14.50.28
31Postoperative thrombocyte (109/L)173.8 ± 59.2182.8 ± 57.80.19
32Postoperative CRP (mg/L)77.7 ± 70.573.1 ± 51.40.48
33Postoperative albumin (g/L)33.6 ± 3.9333.9 ± 3.740.51
34Postoperative CRP/albumin2.41 ± 2.312.23 ± 1.790.50
35AL
Yes311840.59
No4510

AC, adenocarcinoma; ASC, adenosquamous carcinoma; AL, anastomotic leakage; ASA, American Society of Anesthesiologists; BMI, body mass index; CRP, C‐reactive protein; Hb hemoglobin; RATS, robot‐assisted thoracic surgery; RBC, red blood cell; SCC, squamous cell carcinoma; VATS, video‐assisted thoracic surgery; WBC, white blood cell.

Characteristics of patients used in the data set AC, adenocarcinoma; ASC, adenosquamous carcinoma; AL, anastomotic leakage; ASA, American Society of Anesthesiologists; BMI, body mass index; CRP, C‐reactive protein; Hb hemoglobin; RATS, robot‐assisted thoracic surgery; RBC, red blood cell; SCC, squamous cell carcinoma; VATS, video‐assisted thoracic surgery; WBC, white blood cell.

Classification and regression tree (CART) modeling in the training set

The results of univariate analysis in the training set revealed that ASA score, tumor size, pathologic tumor stage, surgical duration, postoperative lymphocyte count, postoperative CRP, preoperative RBC, postoperative albumin, and postoperative CAR were significantly different (P < 0.05). The results are summarized in Table 2.
Table 2

Univariate analysis of factors affecting AL after esophagectomy

No.VariableNon‐AL (n = 311)AL (n = 45) P
1Gender
Male241400.08
Female705
2Age (years)64.26 ± 8.4264.87 ± 8.420.65
3BMI (kg/m2)23.07 ± 3.3122.62 ± 2.560.29
4History of prior chemotherapy and/or radiotherapy
Yes256370.99
No558
5Diabetes
Yes292390.08
No196
6Smoking history
Yes157200.45
No15425
7Drinking history
Yes170290.22
No14116
8Chest operation history
Yes305450.39
No60
9Location of tumor
Upper332
Middle18134
Lower9790.08
10Preoperative WBC (109/L)5.80 ± 1.865.93 ± 2.600.66
11Preoperative lymphocyte (109/L)1.66 ± 0.571.67 ± 0.500.94
12Preoperative neutrophil (109/L)3.60 ± 1.683.75 ± 2.540.59
13Preoperative RBC (1012/L)4.28 ± 0.554.52 ± 0.630.006
14Preoperative Hb (g/L)130.8 ± 20.1136.6 ± 18.40.07
15Preoperative thrombocyte (109/L)187.5 ± 59.1196.3 ± 71.50.36
16Preoperative CRP (mg/L)5.78 ± 15.4210.28 ± 49.250.55
17Preoperative albumin (g/L)41.1 ± 4.6041.65 ± 5.020.47
18ASA score
1263250.00
24116
374
19Method of anastomosis
Cervical anastomosis245380.38
Intrathoracic anastomosis667
20Type of surgery
Open operation156240.55
Vats11718
Rats383
21Tumor size (cm)
< 312090.03
3–513224
> 55912
22Tumor histology
SCC286400.81
AC41
ASC02
Other212
23Pathologic tumor stage
I121190.04
II723
III11020
IV83
24Tumor differentiation
High84110.57
Medium18530
Low424
25Surgical duration (minutes)240.5 ± 63.89286.4 ± 65.790.00
26Postoperative WBC (109/L)11.19 ± 3.3510.64 ± 3.420.31
27Postoperative lymphocyte count (109/L)0.74 ± 0.340.64 ± 0.310.048
28Postoperative neutrophil count (109/L)9.78 ± 3.189.35 ± 3.060.40
29Postoperative RBC (1012/L)3.84 ± 0.583.83 ± 0.640.85
30Postoperative Hb (g/L)117.3 ± 19.7114.8 ± 17.10.41
31Postoperative thrombocyte (109/L)174.23 ± 58.73170.73 ± 63.180.71
32Postoperative CRP (mg/L)64.24 ± 59.15170.5 ± 72.990.00
33Postoperative albumin (g/L)33.81 ± 3.8531.9 ± 4.140.00
34Postoperative CRP/albumin1.96 ± 1.875.52 ± 2.660.00

AC, adenocarcinoma; AL, anastomotic leakage; ASA score, American Society of Anesthesiologists (ASA) score; ASC, adenosquamous carcinoma; BMI, body mass index; CRP, C‐reactive protein; Hb hemoglobin; RATS, robot‐assisted thoracic surgery; RBC, red blood cell; SCC, squamous cell carcinoma; VATS, video‐assisted thoracic surgery; WBC, white blood cell.

Univariate analysis of factors affecting AL after esophagectomy AC, adenocarcinoma; AL, anastomotic leakage; ASA score, American Society of Anesthesiologists (ASA) score; ASC, adenosquamous carcinoma; BMI, body mass index; CRP, C‐reactive protein; Hb hemoglobin; RATS, robot‐assisted thoracic surgery; RBC, red blood cell; SCC, squamous cell carcinoma; VATS, video‐assisted thoracic surgery; WBC, white blood cell. CART analysis was performed using the above nine candidate variables screened by univariate analysis. Postoperative CAR was the most important factor, with normalized importance of 100%. (Fig 1).
Figure 1

Normalized importance of variables in predicting anastomotic leakage (AL) after esophagectomy in decision model tree. ASA, American Society of Anesthesiologists; CAR, C‐reactive protein to to albumin ratio; CRP, C‐reactive protein; CART, classification and regression tree; RBC, red blood cell; TNM, tumor node metastasis.

Normalized importance of variables in predicting anastomotic leakage (AL) after esophagectomy in decision model tree. ASA, American Society of Anesthesiologists; CAR, C‐reactive protein to to albumin ratio; CRP, C‐reactive protein; CART, classification and regression tree; RBC, red blood cell; TNM, tumor node metastasis. In order to avoid overfitting the predictive model, pre‐pruning was performed to ensure the optimal predictive accuracy of the decision tree.23 We removed some variables that were relatively less important (normalized importance < 20%), such as preoperative RBC, tumor node metastasis, tumor size, and ASA score. As illustrated in Figure 2, the ultimate tree model consisted of three variables (postoperative CAR, surgical duration, postoperative lymphocyte count) with four terminal nodes.
Figure 2

Decision tree model for the prediction of anastomotic leakage (AL) in the training set by classification and regression tree analysis. CAR, C‐reactive protein to to albumin ratio.

Decision tree model for the prediction of anastomotic leakage (AL) in the training set by classification and regression tree analysis. CAR, C‐reactive protein to to albumin ratio. By traversing every possible value of each variable, the best split point could be identified by CART algorithm basing on the Gini impurity index24 the cutoff values of the three variables were chosen by the CART algorithm. The postoperative CAR was considered the initial splitting variable, with a cutoff value of 4.25. Among patients with a postoperative CAR ≤ 4.25, surgical duration was considered as the second splitting variable, with a cutoff value of 405 minutes. A low‐risk group was composed of node 3 (postoperative CAR ≤ 4.25, surgical duration ≤ 405 minutes), with a possibility of AL of 3.5% (10/289). A high‐risk group was composed of node 4 (postoperative CAR ≤ 4.25, surgical duration > 405 minutes), with a possibility of AL of 75% (3/4). Among patients with a postoperative CAR > 4.25, the cutoff values were 0.39 for postoperative lymphocytes. A relatively high‐risk group consisted of node 6 (postoperative CAR > 4.25, postoperative lymphocyte > 0.39), with a possibility of AL of 41.5% (22/53). A high‐risk group was made up of node 5 (postoperative CRP/albumin > 4.25, postoperative lymphocyte ≤ 0.39), with a possibility of AL of 100% (10/10). Using all of the variables in the model, we constructed ROC curves to access the accuracy of the CART model. The area under the ROC curve was 0.92 (Fig 3).
Figure 3

Receiver operating characteristic (ROC) curve for the classification and regression tree model in the training set.

Receiver operating characteristic (ROC) curve for the classification and regression tree model in the training set.

Validation of CART analysis in the test set

To evaluate the predictive accuracy of the model, the established CART model was verified in the test set (n = 94). According to the results, the overall sensitivity, specificity, false positive and negative rates, positive and negative predictive values, and diagnostic accuracy of the tree model for AL were 80%, 98.8%, 1.2%, 20%, 88.9%, 97.6%, and 96.8%, respectively (Table 3). An ROC curve for the CART model in the test set was built, the area of which was 0.95 (Fig 4).
Table 3

Performance of the predictive model for AL verified in the test set

Observed
PredictedYesNo
Yes81PPV 88.9% (8/9)
No283NPV 97.6% (83/85)
SensitivitySpecificityDiagnostic accuracy
80% (8/10)98.8% (83/84)96.8%

AL, anastomotic leakage; NPV negative predictive value; PPV positive predictive value.

Figure 4

Receiver operating characteristic (ROC) curve for the classification and regression tree model in the test set.

Performance of the predictive model for AL verified in the test set AL, anastomotic leakage; NPV negative predictive value; PPV positive predictive value. Receiver operating characteristic (ROC) curve for the classification and regression tree model in the test set.

Discussion

AL is defined as an esophagogastrostomy anastomotic dehiscence diagnosed during the postoperative period. If it cannot be diagnosed in time, it may result in disastrous consequences, such as septic shock, mediastinitis, acute respiratory distress syndrome, and death.25 A diagnosis of AL is usually made on the seventh postoperative day, after the onset of clinical symptoms1, 26 Therefore, precise prediction of patients at high risk of AL prior to the incidence of symptoms may decrease morbidity and mortality. In this study, a decision model for predicting the presence of AL in patients after esophagectomy was constructed from a training dataset using the CART algorithm. The accuracy of the prediction model was then validated with a test dataset. According to results verified by the test set, the decision model had good performance and may help clinicians to diagnose and administer treatment in a timely manner. Recently, decision tree algorithms have been found to accomplish the same goals but with fewer assumptions or greater accuracy than other traditional statistical techniques, such as logistic regression analysis27 As a technique that is ideally suited to the generation of clinical decision rules, CART analysis has a number of advantages compared to other traditional statistical methods28, 29 There have been examples of CART tree algorithms being used to create clinical decision rules with proven effectiveness. For instance, one study used CART analysis to develop a decision model that may help clinicians to make an early diagnosis of severe acute pancreatitis30 Another study established a decision tree model for the prediction of congestive heart failure; the sensitivity and specificity of the prediction model were 97.2% and 97.7%, respectively31 Yang Fei et al. designed CART and logistic regression models for the prediction of portosplenomesenteric vein thrombosis and found that the CART model demonstrated better overall properties than the logistic regression model11 However, CART analysis has not been used to predict the occurrence of AL after esophagectomy. In the present study, we presupposed that the novel indicator CAR might be a potential predictor for AL in patients after esophagectomy. CAR is a composite indicator composed of CRP and albumin, which means that if the three indicators (CAR, CRP, and albumin) were applied to multiple regression analysis, the collinearity between them will affect the accuracy of the regression equation and contribute to unreliable results14 However, CART analysis is not hindered by multicollinearity; collinearity is often used to an advantage in tree algorithms32 As illustrated in Figure 1, we successfully integrated the three indicators into the prediction model using CART analysis and obtained their normalized importance for AL, which were 100%, 79.2%, and 21.8%, respectively. According to the results verified in the test set, the area under ROC curve revealed that the CART model had good predictive accuracy (sensitivity 80%, specificity 98.8%, diagnostic accuracy 96.8%, area under ROC curve 0.95). CAR was identified as the most important indicator of AL in this trial. The novel index CAR, as a sensitive marker of systemic inflammatory response, is a potential predictive indicator for clinical outcomes. For example, one study showed that CAR at admission can be used as an independent predictor of 180‐day mortality in patients with severe sepsis or septic shock and proved the predictive value of the indicator33 Gibson et al. found that elevated CAR is an early predictor of steroid‐refractory acute severe ulcerative colitis.34 In our study, we clarified the association between CAR and AL; patients with elevated CAR on POD 3 had a higher tendency to develop AL, approximately four days prior to the median time to AL diagnosis. This indicates that clinicians could monitor these indicators to determine patients at high risk of AL, prior to the appearance of clinical symptoms. To exclude AL in high‐risk patients we could conduct close clinical assessment and radiological examination in our center; however, we prefer to continue with the administration of enteral nutrition to low‐risk patients. This measure may bring significant benefits to patients because postoperative enteral nutrition has been proven to reduce the incidence of life‐threatening surgical complications and improve the completion rate of clinical pathways for thoracic esophagectomy35 In conclusion, the decision tree model (consisting of surgical duration, postoperative lymphocyte count, and postoperative CAR) showed good performance for predicting AL after esophagectomy using the CART algorithm; the CAR was proven the key indicator to the model. The CART model may help clinicians to identify patients at high risk of developing AL and to administer timely treatment.

Disclosure

No authors report any conflict of interest.
  31 in total

1.  A tree-based decision rule for identifying profile groups of cases without predefined classes: application in diffuse large B-cell lymphomas.

Authors:  Elias Zintzaras; Maria Bai; Christos Douligeris; Axel Kowald; Panayiotis Kanavaros
Journal:  Comput Biol Med       Date:  2006-08-08       Impact factor: 4.589

2.  Preoperative Glycosylated Hemoglobin Levels Predict Anastomotic Leak After Esophagectomy with Cervical Esophagogastric Anastomosis.

Authors:  Akihiko Okamura; Masayuki Watanabe; Yu Imamura; Satoshi Kamiya; Kotaro Yamashita; Takanori Kurogochi; Shinji Mine
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

3.  Evaluation of a Decision Tree for Efficient Antenatal Red Blood Cell Antibody Screening.

Authors:  Isabelle Le Ray; Brian Lee; Agneta Wikman; Marie Reilly
Journal:  Epidemiology       Date:  2018-05       Impact factor: 4.822

4.  Procalcitonin, as an early biomarker of colorectal anastomotic leak, facilitates enhanced recovery after surgery.

Authors:  V Giaccaglia; P F Salvi; G V Cunsolo; A Sparagna; M S Antonelli; G Nigri; G Balducci; V Ziparo
Journal:  J Crit Care       Date:  2014-04-05       Impact factor: 3.425

5.  Decision-making model for early diagnosis of congestive heart failure using rough set and decision tree approaches.

Authors:  Chang-Sik Son; Yoon-Nyun Kim; Hyung-Seop Kim; Hyoung-Seob Park; Min-Soo Kim
Journal:  J Biomed Inform       Date:  2012-05-04       Impact factor: 6.317

6.  C-reactive protein for the early prediction of anastomotic leak after esophagectomy in both neoadjuvant and non-neoadjuvant therapy case: a propensity score matching analysis.

Authors:  Jae Kil Park; Jae Jun Kim; Seok Whan Moon
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

7.  The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy.

Authors:  Min Hyung Kim; Jin Young Ahn; Je Eun Song; Heun Choi; Hea Won Ann; Jae Kyoung Kim; Jung Ho Kim; Yong Duk Jeon; Sun Bean Kim; Su Jin Jeong; Nam Su Ku; Sang Hoon Han; Young Goo Song; Jun Young Choi; Young Sam Kim; June Myung Kim
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

8.  Enhanced Recovery After Surgery: Which Components, If Any, Impact on The Systemic Inflammatory Response Following Colorectal Surgery?: A Systematic Review.

Authors:  David G Watt; Stephen T McSorley; Paul G Horgan; Donald C McMillan
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

9.  Prediction of Severe Acute Pancreatitis Using a Decision Tree Model Based on the Revised Atlanta Classification of Acute Pancreatitis.

Authors:  Zhiyong Yang; Liming Dong; Yushun Zhang; Chong Yang; Shanmiao Gou; Yongfeng Li; Jiongxin Xiong; Heshui Wu; Chunyou Wang
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

10.  Analysis of risk factors for post-operative complications and prognostic predictors of disease recurrence following definitive treatment of patients with esophageal cancer from two medical centers in Northwest China.

Authors:  Jichang Wang; Boxiang Zhang; Jinying Meng; Guodong Xiao; Xiang Li; Gang Li; Sida Qin; Ning Du; Jia Zhang; Jing Zhang; Chongwen Xu; Shou-Ching Tang; Rui Liang; Hong Ren; Xin Sun
Journal:  Exp Ther Med       Date:  2017-07-25       Impact factor: 2.447

View more
  2 in total

Review 1.  Machine learning applications in upper gastrointestinal cancer surgery: a systematic review.

Authors:  Mustafa Bektaş; George L Burchell; H Jaap Bonjer; Donald L van der Peet
Journal:  Surg Endosc       Date:  2022-08-11       Impact factor: 3.453

2.  Constructing a risk prediction model for anastomotic leakage after esophageal cancer resection.

Authors:  Zhong-Wen Sun; Hui Du; Jia-Rui Li; Hui-Ying Qin
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.